Objective To assess the inspiratory demand in young infants with acute viral bronchiolitis to
provide a physiological basis for initial flow setting for patients supported with high flow …

Purpose The high flow nasal cannula (HFNC) has recently been proposed to support infants
with respiratory syncytial virus (RSV)-related respiratory distress. However, in this disease …

Objectives To determine whether in infants with bronchiolitis admitted to a pediatric intensive
care unit (PICU) the starting rate for high‐flow nasal cannula (HFNC) therapy set by the …

Introduction High‐flow nasal cannula (HFNC) is commonly used as first step respiratory
support in infants with moderate‐to‐severe acute viral bronchiolitis (AVB). This device …

Objective: To assess the effect of delivering high-flow nasal cannula flow on end-expiratory
lung volume, continuous distending pressure, and regional ventilation distribution in infants …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

Objectives: Viral bronchiolitis is an acute infection and inflammatory disease of the
respiratory tract, with infants typically presenting with the most severe symptoms. Medical …

Oxygen delivery via a high flow nasal cannula (HFNC) system has become increasingly
common for children with acute viral bronchiolitis. 1 HFNC is now used in pediatric intensive …

Continuous positive airway pressure (CPAP) has been used in infants with bronchiolitis for
decades. Recently, high flow nasal cannula (HFNC) therapy was introduced. We conducted …

Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …